"Though public health experts have long advised the use of condoms for anal sex to protect against H.I.V. and other infections, regulators did not have enough data to allow marketing for that use,"
according to
The New York Times. Now they do, as one study showed "the failure rate, defined as slippage or breakage, to be less than 1 percent during anal sex." The FDA's decision to allow
marketing for that purpose applies just to the company that did the study -- Global Protection Corp. for the ONE male condom -- but other companies can apply for approval by providing similar
data on their products.
Read the whole story at The New York Times »
